Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Jarrard

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
British Journal of Cancer|May 12, 2021
Tandem histone methyltransferase upregulation defines a unique aggressive prostate cancer phenotypeMikolaj Filon, Joseph Gawdzik, Andrew Truong, et al.
The American Journal of Pathology|January 21, 2023
Fusion Gene Detection in Prostate Cancer Samples Enhances the Prediction of Prostate Cancer Clinical Outcomes from Radical Prostatectomy through Machine Learning in a Multi-Institutional AnalysisYan-Ping Yu, Silvia Liu, Bao-Guo Ren, et al.
The Prostate|January 22, 2013
Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pinJason Gee, Howard Bailey, Kyungmann Kim, et al.
American Journal of Clinical and Experimental Urology|October 22, 2016
Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D<sub>3</sub>) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomyDavid Jarrard, Badrinath Konety, Wei Huang, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 28, 2015
Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomyJason R Gee, Daniel R Saltzstein, Edward Messing, et al.
The Prostate|October 23, 2020
A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillanceDavid Jarrard, Mikolaj Filon, Wei Huang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2006
Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasiaJames R Marshall, Wael Sakr, David Wood, et al.
The Journal of Urology|May 13, 2026
Semen RNA-Based Biomarkers for Prostate Cancer Detection and Risk Stratification: A Prospective Multi-Center Validation StudyDuncan H Whitney, Matthew Clay, Joel Wipperfurth, et al.
The American Journal of Pathology|September 21, 2014
Novel fusion transcripts associate with progressive prostate cancerYan P Yu, Ying Ding, Zhanghui Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2017
Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without DocetaxelLauren C Harshman, Yu-Hui Chen, Glenn Liu, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|May 12, 2021
Tandem histone methyltransferase upregulation defines a unique aggressive prostate cancer phenotypeMikolaj Filon, Joseph Gawdzik, Andrew Truong, et al.
The American Journal of Pathology|January 21, 2023
Fusion Gene Detection in Prostate Cancer Samples Enhances the Prediction of Prostate Cancer Clinical Outcomes from Radical Prostatectomy through Machine Learning in a Multi-Institutional AnalysisYan-Ping Yu, Silvia Liu, Bao-Guo Ren, et al.
The Prostate|January 22, 2013
Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pinJason Gee, Howard Bailey, Kyungmann Kim, et al.
American Journal of Clinical and Experimental Urology|October 22, 2016
Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D<sub>3</sub>) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomyDavid Jarrard, Badrinath Konety, Wei Huang, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 28, 2015
Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomyJason R Gee, Daniel R Saltzstein, Edward Messing, et al.
The Prostate|October 23, 2020
A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillanceDavid Jarrard, Mikolaj Filon, Wei Huang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2006
Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasiaJames R Marshall, Wael Sakr, David Wood, et al.
The Journal of Urology|May 13, 2026
Semen RNA-Based Biomarkers for Prostate Cancer Detection and Risk Stratification: A Prospective Multi-Center Validation StudyDuncan H Whitney, Matthew Clay, Joel Wipperfurth, et al.
The American Journal of Pathology|September 21, 2014
Novel fusion transcripts associate with progressive prostate cancerYan P Yu, Ying Ding, Zhanghui Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2017
Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without DocetaxelLauren C Harshman, Yu-Hui Chen, Glenn Liu, et al.
Pageof 4